Preeclamptic hPDMSCs (Corion biotech)

先兆子痫胎盘间充质干细胞疗法（corion biotech）

Report date: 2023/06/28 16:02:28

Base Information

Drug NamePreeclamptic hPDMSCs (Corion biotech)
Drug Alias NameCB-ChMF-12
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsNeoplasms, Fibroepithelial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesEurope +[6] 
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaPending
Originator CompaniesCorion Biotech SRL
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCorion Biotech SRL
Active IndicationsN/A
Inactive IndicationsNeoplasms, Fibroepithelial

Other Information

ATC CodeN/A
Related LinksN/A